Crystec Pharma

Stand: 233

Telephone: 01274 235592
Email: emily.bevis@crystecpharma.com
Website: http://www.crystecpharma.com
Address: Norcroft Building, Richmond Road, Bradford, BD7 1DP,

Company Profile

Crystec provide crystal and particle engineering solutions to the pharmaceutical and biopharmaceutical industries through application of the latest modified Supercritical Anti-Solvent (mSASĀ®) technology. We work with clients to help overcome development challenges, and apply the platform to our own assets.
Our services include enhanced polymorph screening, improving stability and generation of scalable co-crystals. The platform is an attractive, single-step alternative to conventional techniques (e.g. micronisation) in terms of process robustness, and ability to control the physical and solid-state properties of the most problematic compounds. mSAS is scaled to commercial GMP, facilitating a rapid transition from feasibility studies to clinical supply.

    « Back